Yuhua Ran
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Dual-Membrane Biomimetic Nanoplatform Enables Triple-Modal Therapy Against SARS-CoV-2 Through Viral Decoy, Inflammation Neutralizing, and Intracellular RNAi.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 02, 2026
A Brain-Targeted Organophosphorus Hydrolase Fusion Protein Mediated by Angiopep-2 Neutralizes Central Organophosphates and Alleviates Neurotoxicity.
Journal: International journal of nanomedicine
Published: February 19, 2026
Polymeric particle-based antigen delivery system: From immunological engineering to clinical translation.
Journal: International journal of pharmaceutics: X
Published: October 10, 2025
Nanocarrier-based immunotherapy for viral diseases.
Journal: International journal of pharmaceutics: X
Published: June 11, 2025
Corrigendum: Hypidone hydrochloride (YL-0919) produces a fast-onset reversal of the behavioral and synaptic deficits caused by chronic stress exposure.
Journal: Frontiers in cellular neuroscience
Published: January 27, 2025
Pembrolizumab versus sintilimab in patients with advanced NSCLC: a retrospective multicenter study with propensity-score matching analysis.
Journal: Frontiers in oncology
Published: April 23, 2024
Pleiotropic Effects of Simvastatin on the Regulation of Potassium Channels in Monocytes.
Journal: Frontiers in pharmacology
Published: January 14, 2019
Hypidone Hydrochloride (YL-0919) Produces a Fast-Onset Reversal of the Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure.
Journal: Frontiers in cellular neuroscience
Published: May 18, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026